>MNTA – How significant is the following item, in your opinion? “M118 has shown approximately half the bleeding risk of unfractionated heparin in preclinical and clinical studies to date.”<
If borne out, it would be quite significant, IMO. All anticoagulant and antiplatelet drugs entail a tradeoff between thrombosis and bleeding to some degree, but the degree matters a lot.
Market Data 
Markets 
AI
